Protalix BioTherapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
86,760.00
55,183.00
76,745.00
63,758.00
51,786.00
38,369
Total Accounts Receivable
2,091.00
1,884.00
-
693.00
1,721.00
4,729
Inventories
7,957.00
6,667.00
5,767.00
5,245.00
7,833.00
8,569
Other Current Assets
1,095.00
1,786.00
3,369.00
2,171.00
1,311.00
1,316
Total Current Assets
97,903.00
65,520.00
85,881.00
71,867.00
62,651.00
52,983
Net Property, Plant & Equipment
13,711.00
11,282.00
9,744.00
8,703.00
7,676.00
6,390
Other Assets
1,719.00
1,668.00
1,628.00
1,677.00
1,887.00
1,758
Total Assets
113,333.00
78,470.00
97,253.00
82,247.00
72,214.00
61,131
ST Debt & Current Portion LT Debt
-
-
-
53,872.00
5,921.00
Accounts Payable
5,254.00
3,951.00
3,629.00
4,007.00
7,521.00
Other Current Liabilities
21,442.00
22,259.00
7,606.00
8,333.00
9,310.00
Total Current Liabilities
26,696.00
26,210.00
11,235.00
66,212.00
22,752.00
Long-Term Debt
67,048.00
67,464.00
72,097.00
23,644.00
46,267.00
Provision for Risks & Charges
2,368.00
2,253.00
2,304.00
2,348.00
2,586.00
Other Liabilities
44,167.00
38,144.00
744.00
-
31,902.00
Total Liabilities
140,279.00
134,071.00
86,380.00
92,204.00
103,507.00
Common Equity (Total)
26,946.00
55,601.00
10,873.00
9,957.00
31,293.00
Total Shareholders' Equity
26,946.00
55,601.00
10,873.00
9,957.00
31,293.00
Total Equity
26,946.00
55,601.00
10,873.00
9,957.00
31,293.00
Liabilities & Shareholders' Equity
113,333.00
78,470.00
97,253.00
82,247.00
72,214.00
About Protalix BioTherapeutics
View Profile
